In vitro activity of BAL30072 against Burkholderia pseudomallei
- 31 August 2011
- journal article
- research article
- Published by Elsevier BV in International Journal of Antimicrobial Agents
- Vol. 38 (2), 157-159
- https://doi.org/10.1016/j.ijantimicag.2011.03.019
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The BpeAB-OprB Efflux Pump of Burkholderia pseudomallei 1026b Does Not Play a Role in Quorum Sensing, Virulence Factor Production, or Extrusion of Aminoglycosides but Is a Broad-Spectrum Drug Efflux SystemAntimicrobial Agents and Chemotherapy, 2010
- In Vitro Properties of BAL30072, a Novel Siderophore Sulfactam with Activity against Multiresistant Gram-Negative BacilliAntimicrobial Agents and Chemotherapy, 2010
- Activity of the siderophore monobactam BAL30072 against multiresistant non-fermentersJournal of Antimicrobial Chemotherapy, 2009
- Molecular Basis of Rare Aminoglycoside Susceptibility and Pathogenesis of Burkholderia pseudomallei Clinical Isolates from ThailandPLoS Neglected Tropical Diseases, 2009
- Management of melioidosisExpert Review of Anti-infective Therapy, 2006
- Melioidosis: insights into the pathogenicity of Burkholderia pseudomalleiNature Reviews Microbiology, 2006
- Genetic and Transcriptional Analysis of the Siderophore Malleobactin Biosynthesis and Transport Genes in the Human Pathogen Burkholderia pseudomallei K96243Journal of Bacteriology, 2006
- Melioidosis: Epidemiology, Pathophysiology, and ManagementClinical Microbiology Reviews, 2005
- Efflux-Mediated Aminoglycoside and Macrolide Resistance in Burkholderia pseudomalleiAntimicrobial Agents and Chemotherapy, 1999
- Pseudomonas pseudomallei resistance to beta-lactam antibiotics due to alterations in the chromosomally encoded beta-lactamaseAntimicrobial Agents and Chemotherapy, 1991